EP Patent

EP3568082A4 — METHOD OF USING HUMAN EXCREMENTS AND SECRETS FOR THE EARLY DETECTION OF PARKINSON'S DISEASE

Assigned to Neurrx Spc · Expires 2020-12-09 · 5y expired

What this patent protects

Patent listed against safinamide-mesylate.

Drugs covered by this patent

safinamide-mesylate (SAFINAMIDE MESYLATE)

Patent Metadata

Patent number: EP3568082A4
Jurisdiction: EP
Classification: —
Expires: 2020-12-09
Drug substance claim: No
Drug product claim: No
Assignee: Neurrx Spc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.